AKBM Fundamental Analysis - AKER BIOMARINE ASA

Fundamental Rating

Overall AKBM gets a fundamental rating of 4 out of 10. We evaluated AKBM against 58 industry peers in the Food Products industry. AKBM has a medium profitability rating, but doesn't score so well on its financial health evaluation. AKBM has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AKBM was profitable.

In the past year AKBM had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: AKBM reported negative net income in multiple years.

Of the past 5 years AKBM 4 years had a positive operating cash flow.

1.2 Ratios

AKBM has a better Return On Assets (44.73%) than 100.00% of its industry peers.

Looking at the Return On Equity, with a value of 115.79%, AKBM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

With a Return On Invested Capital value of 1.30%, AKBM is not doing good in the industry: 75.86% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	44.73%
ROE	115.79%
ROIC	1.3%

ROA(3y)16.04%

ROA(5y)9.26%

ROE(3y)36.62%

ROE(5y)21.25%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 67.04%, AKBM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

The Operating Margin of AKBM (2.05%) is worse than 72.41% of its industry peers.

AKBM has a Gross Margin (43.26%) which is comparable to the rest of the industry.

AKBM's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	2.05%
PM (TTM)	67.04%
GM	43.26%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.45%

GM growth 5Y0.36%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKBM is destroying value.

AKBM has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, AKBM has about the same amount of shares outstanding.

The debt/assets ratio for AKBM has been reduced compared to a year ago.

2.2 Solvency

AKBM has an Altman-Z score of 1.61. This is a bad value and indicates that AKBM is not financially healthy and even has some risk of bankruptcy.

AKBM has a Altman-Z score of 1.61. This is in the lower half of the industry: AKBM underperforms 68.97% of its industry peers.

A Debt/Equity ratio of 1.06 is on the high side and indicates that AKBM has dependencies on debt financing.

AKBM has a worse Debt to Equity ratio (1.06) than 77.59% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	N/A
Altman-Z	1.61

ROIC/WACC0.15

WACC8.46%

2.3 Liquidity

AKBM has a Current Ratio of 2.62. This indicates that AKBM is financially healthy and has no problem in meeting its short term obligations.

AKBM's Current ratio of 2.62 is amongst the best of the industry. AKBM outperforms 82.76% of its industry peers.

AKBM has a Quick Ratio of 1.25. This is a normal value and indicates that AKBM is financially healthy and should not expect problems in meeting its short term obligations.

AKBM has a better Quick ratio (1.25) than 74.14% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.62
Quick Ratio	1.25

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AKBM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15747.24%, which is quite impressive.

Looking at the last year, AKBM shows a very negative growth in Revenue. The Revenue has decreased by -15.34% in the last year.

AKBM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.17% yearly.

EPS 1Y (TTM)15747.24%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)-15.34%

Revenue growth 3Y-8.77%

Revenue growth 5Y-4.17%

Sales Q2Q%-41.17%

3.2 Future

AKBM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 97.75% yearly.

Based on estimates for the next years, AKBM will show a very strong growth in Revenue. The Revenue will grow by 20.59% on average per year.

EPS Next Y60%

EPS Next 2Y119.09%

EPS Next 3Y97.75%

EPS Next 5YN/A

Revenue Next Year-14.23%

Revenue Next 2Y-1.01%

Revenue Next 3Y2.72%

Revenue Next 5Y20.59%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.65, the valuation of AKBM can be described as very cheap.

Based on the Price/Earnings ratio, AKBM is valued cheaper than 94.83% of the companies in the same industry.

AKBM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.86.

The Price/Forward Earnings ratio is 37.77, which means the current valuation is very expensive for AKBM.

Based on the Price/Forward Earnings ratio, AKBM is valued a bit more expensive than 67.24% of the companies in the same industry.

AKBM is valuated expensively when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	4.65
Fwd PE	37.77

4.2 Price Multiples

75.86% of the companies in the same industry are cheaper than AKBM, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	21.49

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as AKBM's earnings are expected to grow with 97.75% in the coming years.

PEG (NY)0.08

PEG (5Y)N/A

EPS Next 2Y119.09%

EPS Next 3Y97.75%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AKBM does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AKER BIOMARINE ASA

OSL:AKBM (10/6/2025, 3:57:51 PM)

+0.1 (+0.11%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)07-11 2025-07-11/bmo

Earnings (Next)10-31 2025-10-31

Inst Owners7%

Inst Owner ChangeN/A

Ins Owners3.22%

Ins Owner ChangeN/A

Market Cap8.07B

Analysts77.78

Price Target86.7 (-5.76%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend42.35

Dividend Growth(5Y)N/A

DP215.6%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)21.43%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)-20%

EPS NY rev (3m)-11.11%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-4.84%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.44%

Valuation

		Industry Rank	Sector Rank
PE	4.65
Fwd PE	37.77
P/S	3.14
P/FCF	N/A
P/OCF	197.79
P/B	5.42
P/tB	29.6
EV/EBITDA	21.49

EPS(TTM)19.77

EY21.49%

EPS(NY)2.44

Fwd EY2.65%

FCF(TTM)-1.72

FCFYN/A

OCF(TTM)0.47

OCFY0.51%

SpS29.29

BVpS16.96

TBVpS3.11

PEG (NY)0.08

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	44.73%
ROE	115.79%
ROCE	1.69%
ROIC	1.3%
ROICexc	1.39%
ROICexgc	2.38%
OM	2.05%
PM (TTM)	67.04%
GM	43.26%
FCFM	N/A

ROA(3y)16.04%

ROA(5y)9.26%

ROE(3y)36.62%

ROE(5y)21.25%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.45%

GM growth 5Y0.36%

F-Score5

Asset Turnover0.67

Health

		Industry Rank	Sector Rank
Debt/Equity	1.06
Debt/FCF	N/A
Debt/EBITDA	3.5
Cap/Depr	48.25%
Cap/Sales	7.47%
Interest Coverage	0.39
Cash Conversion	9.05%
Profit Quality	N/A
Current Ratio	2.62
Quick Ratio	1.25
Altman-Z	1.61

F-Score5

WACC8.46%

ROIC/WACC0.15

Cap/Depr(3y)77.43%

Cap/Depr(5y)88.04%

Cap/Sales(3y)14.31%

Cap/Sales(5y)16.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)15747.24%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

EPS Next Y60%

EPS Next 2Y119.09%

EPS Next 3Y97.75%

EPS Next 5YN/A

Revenue 1Y (TTM)-15.34%

Revenue growth 3Y-8.77%

Revenue growth 5Y-4.17%

Sales Q2Q%-41.17%

Revenue Next Year-14.23%

Revenue Next 2Y-1.01%

Revenue Next 3Y2.72%

Revenue Next 5Y20.59%

EBIT growth 1Y60.61%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year172.92%

EBIT Next 3Y67.85%

EBIT Next 5YN/A

FCF growth 1Y62.56%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-14.58%

OCF growth 3Y155.79%

OCF growth 5Y-0.17%

AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens